ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza (RICH-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01066169
Recruitment Status : Completed
First Posted : February 10, 2010
Last Update Posted : January 30, 2012
Sponsor:
Collaborator:
Erasmus Medical Center
Information provided by:
Leiden University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2010
  Actual Study Completion Date : February 2010